HER2-negative carcinomas showed more diverse transcriptomic profiles, without a single distinctive cluster, contrary to HER2-positive carcinomas which had a specific and homogeneous transcriptomic profile, clearly distinguishing these carcinomas from other carcinomas. Here, ERBB2 is linked to carcinoma.